Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Perspectives of contraception]

S Christin-Maitre1, N Chabbert-Buffet, I Leroy

  • 1Service d'endocrinologie, Hôpital Saint-Antoine, Paris.

La Revue Du Praticien
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using machine learning to discriminate non-classical 21-hydroxylase deficiency from polycystic ovary syndrome: an external validation study.

European journal of endocrinology·2026
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

Canadian journal of surgery. Journal canadien de chirurgie·2025
Same author

Fluorescence angiography with indocyanine green for low anterior resection in patients with rectal cancer: a prospective before and after study.

Techniques in coloproctology·2025
Same author

Towards the standardization of Hydra vulgaris bioassay for toxicity assessments of liquid samples.

Ecotoxicology and environmental safety·2024
Same author

Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4).

Frontiers in global women's health·2024
Same author

[Transition, fertility and options for preservation of fertility].

Annales de chirurgie plastique et esthetique·2023
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Meeting global population growth requires accessible, effective contraceptives. Research focuses on new hormonal contraceptives, including low-dose options and intrauterine devices, to improve reproductive health and family planning worldwide.

Area of Science:

  • Reproductive Health
  • Endocrinology
  • Pharmacology

Context:

  • Global population projected to reach 6 billion, necessitating increased access to contraception.
  • Urgent need for well-tolerated, efficient, and low-cost contraceptive options for women.
  • Advancements in contraceptive technology are crucial for global reproductive health initiatives.

Purpose:

  • To inform women about reproductive health and contraceptive options.
  • To introduce novel contraceptive molecules and delivery systems.
  • To explore future contraceptive strategies, including hormonal and immunological approaches.

Summary:

  • Development of low-dose estroprogestins with non-androgenic progestins and 17 beta-estradiol.
  • Evaluation of mifepristone (RU 486) as a post-coital contraceptive pill.

Related Experiment Videos

  • Investigation of intrauterine devices (IUDs) containing levonorgestrel or desogestrel.
  • Research into daily low-dose antiprogestins for endometrial maturation interference.
  • Exploration of future contraceptive targets such as anti-FSH molecules and tissue-specific steroids.

    • Impact:

    • Enhancing women's reproductive autonomy through improved contraceptive access and choices.
    • Potentially reducing unintended pregnancies and supporting family planning globally.
    • Contributing to the development of next-generation contraceptives with improved efficacy and tolerability.